Amprius logo over a lab battery cell, highlighting advanced lithium battery tech and AMPX stock focus. Key Points Amprius Technologies insider selling was executed under a 10b5-1 plan, and insiders still own nearly 13% of the company. Institutional interest and analyst sentiment remain supportive, with improving accumulation and a Buy-leaning rating mix. NDAA-compliant capacity expansion, strong revenue growth expectations, and easing short interest set up catalysts ahead. Interested in Amprius Techno ...